Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.
Hirsiger JR, Martinez M, Tsakiris DA, Cittone MG, Graf L, Oldenburg J, Pezeshkpoor B, Recher M, Mueller J, Gerber B, Berger CT. Hirsiger JR, et al. Among authors: berger ct. J Thromb Haemost. 2022 Apr;20(4):1015-1018. doi: 10.1111/jth.15665. Epub 2022 Feb 13. J Thromb Haemost. 2022. PMID: 35108443 Free PMC article. No abstract available.
Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.
Bigler MB, Egli SB, Hysek CM, Hoenger G, Schmied L, Baldin FS, Marquardsen FA, Recher M, Liechti ME, Hess C, Berger CT. Bigler MB, et al. Among authors: berger ct. PLoS One. 2015 Dec 23;10(12):e0145635. doi: 10.1371/journal.pone.0145635. eCollection 2015. PLoS One. 2015. PMID: 26700184 Free PMC article. Clinical Trial.
A 'Too Negative' ANA Test Predicts Antibody Deficiency.
Recher M, Berger CT, Daikeler T, Hess C, Heijnen IA. Recher M, et al. Among authors: berger ct. J Clin Immunol. 2016 May;36(4):374-6. doi: 10.1007/s10875-016-0262-9. Epub 2016 Mar 10. J Clin Immunol. 2016. PMID: 26961361 No abstract available.
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.
Navarini AA, Hruz P, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M. Navarini AA, et al. Among authors: berger ct. J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5. doi: 10.1016/j.jaci.2016.08.042. Epub 2016 Nov 28. J Allergy Clin Immunol. 2017. PMID: 27908448 No abstract available.
Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.
Kistner A, Bigler MB, Glatz K, Egli SB, Baldin FS, Marquardsen FA, Mehling M, Rentsch KM, Staub D, Aschwanden M, Recher M, Daikeler T, Berger CT. Kistner A, et al. Among authors: berger ct. Rheumatology (Oxford). 2017 May 1;56(5):829-834. doi: 10.1093/rheumatology/kew469. Rheumatology (Oxford). 2017. PMID: 28064210
Low immunoglobulin E flags two distinct types of immune dysregulation.
Elkuch M, Greiff V, Berger CT, Bouchenaki M, Daikeler T, Bircher A, Navarini AA, Heijnen I, Recher M. Elkuch M, et al. Among authors: berger ct. Clin Exp Immunol. 2017 Mar;187(3):345-352. doi: 10.1111/cei.12885. Epub 2017 Jan 11. Clin Exp Immunol. 2017. PMID: 28078662 Free PMC article.
94 results